CAMBER SPINE TECHNOLOGIES ANNOUNCES FIRST IMPLANTATION OF ENZA™ ZERO-PROFILE ALIF DEVICE

IMG_2704 copy.jpg
FullSizeRender4.jpg
enza_HiRes_01 copy.png

Camber Spine Technologies, today announced the first implantation of the ENZA™ MIS Zero-Profile Anterior Lumbar Interbody Fusion (ALIF) device in a two-level lumbar procedure at levels L4/L5 and L5/S1 at Kennedy University Hospital, Washington Township, by Dr. Jeffrey Gleimer, D.O.  ENZA™ is the company’s first device launched with integrated fixation to promote minimally invasive mechanical fusion.

“Today I implanted the ENZA ALIF device in a patient to replace two damaged discs.  The brilliant design of the implant has perfected true direct midline fixation within the retroperitoneal space for lumbar fusion.  The ENZA ALIF device far surpasses its competitors in providing a simple, easy to implant device with superior osseous fixation, even in significantly sclerotic bone, while also significantly reducing my operative time.  I’m excited to be a part of the team bringing this device to the market and looking forward to improved patient outcomes across the country and hopefully the world!”
-Dr. Jeffrey Gleimer, D.O. 

The Camber Spine Technologies ENZA™ MIS Zero-Profile ALIF device is indicated for use with autogenous bone graft in patients with degenerative disc disease (DDD) at one or two contiguous levels from L2 to S1. These implants may be implanted via laparascopic or an open anterior approach. The Camber Spine Technologies’ ENZA™ MIS Zero-Profile ALIF is intended to be used with additional FDA-cleared supplementary fixation systems.  

Camber MedTech